The main objective of the conference is to bring together dentists, experts in dentistry development and other specialists to exchange their ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations. With members from around the world focused on learning about dental and oral health in making a better health; this is your best opportunity to reach the largest assemblage of participants from the Dentistry community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, new treatment techniques and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in dental and oral health are hallmarks of this conference.

Read on dental.conferenceseries.com

Biosensors and Bioelectronics 2023 Organizing Committee, is a great pleasure and an honor to extend you a warm invitation to attend 17th International Conference and Exhibition on Biosensors & Bioelectronics during April 12-13, 2023 in Vancouver, Canada with the theme "Future trends development and new intervention in biosensors technologies". Biosensors and Bioelectronics 2023 conference explores new advances and recent updated technologies. It is your high eminence that you enhance your research work in this field. Biosensors conference deals with recent advances in the field of biosensors like security and sensing, photonic sensor technologies, Biosensors for imaging and many more. Biosensors congress provides a unique platform for people who conduct their research work in this field. The conference captivates individuals both from commercial and academic worlds yet establishes a firm link and binds us together with the recent updated accomplishments. We provide a good opportunity by admiring your updated research knowledge and also by publishing it in our respective Journals. The congress ultimately provides a good gathering of bright personalities to update us the new research on Biosensors.

Read on biosensors.conferenceseries.com

Clinical documentation burden has snowballed so much that the American Medical Informatics Association devoted a multiyear effort to substantially reduce documentation burden by 2025, recognizing the stress it imposes on physicians and negative outcomes that ensue like overworked staff, less job satisfaction and medical errors. Some hospitals and health systems are using technology to address this issue as part of staff retention initiatives, as well as larger efforts to improve productivity, accuracy and operations of surgical teams. This live webinar will feature a panel of leaders from Johnson City, Tenn.-based Ballad Health, University of California San Diego Health and Massachusetts-based Nuance Communications, who will share their perspectives on using technology like intelligent workflows and AI-powered tools to streamline surgical documentation and enhance physician-patient experiences.

Read on go.beckershospitalreview.co

Medical Devices Group Conference where the entire medical device ecosystem convenes to grow your skills, network, and profit. 10x Medical Device Conference is the cross-functional event where the medical device industry unites to grow your skills, network, and profit. It’s designed to foster strong professional relationships among medical device players eager to learn smarter ways to do things with industry-leading resources. This will be our thirteenth event.

Read on 10xmedicaldeviceevents.com

s clinical research in the oncology therapeutic area becomes increasingly complex, effectively capturing high-quality data across multiple endpoints becomes even more critical to a drug’s success. Many oncologic agents have cardiac toxicities, including depression of left ventricular function, QTc prolongation and elevation of blood pressure. Register for this webinar to learn about the intersection of oncology drug development and cardiac safety, and how this new area is changing the landscape for early-phase clinical trials. Cardio-oncology, an evolving subspecialty focused specifically on the detection and management of these risks, has become an essential consideration within any oncology development program. Additionally, with the growing emphasis on patient-focused drug development, recent regulatory guidelines now outline core patient-reported outcomes (PROs) that should be included in oncology clinical trials. Among these are self-reported symptomatic adverse events, with the new 2023 US Food and Drug Administration (FDA) draft guidance acknowledging the importance of utilizing this self-reported data to enhance the assessment of tolerability in early-phase dose optimization trials.

Read on xtalks.com

Please join the Asia America Multitechnology Association (AAMA), the world's largest pan-Asian tech organization, for our HealthTech Event. The AAMA Silicon Valley and Silicon Valley Bank are excited to invite you to join The AAMA Digital Healthcare Connect Conference, an innovative half-day event on how healthcare technologies are being disrupted globally. Healthcare and LifeSciences are projected to be multi-$Billion industries in 2030.

Read on eventbrite.com

During this webinar, Ahmed Foda, MD, cardiologist and CMIO for ambulatory practices at Temple University Health System will discuss how he helped create and deploy a robust clinician adoption, optimization and support program to improve the utilization and usage of their speech recognition solution, Dragon Medical One. He will share the tactics and strategies his team used to improve time savings, reduce clinician burnout and streamline their clinical documentation workflow.
 
This 60-minute webinar will provide you with the knowledge to:

• Breakdown the primary objectives of Temple Health’s EPOCH program
• Examine how physician buy-in and speech recognition solution adoption were achieved, along with metrics and key performance indicators (KPIs)
• Distinguish specific training examples that led to long-term success and recommendations on how to optimize physician training programs

Read on mgma.com

From discovery to clinical development, the field of protein degradation is booming with excitement, with a whole host of investments and new companies joining the effort to successfully degrade unwanted or undrugged targets with key roles in a broad range of diseases from oncology to CNS, through to autoimmune.

Despite this, key challenges remain to rapidly and successfully discover novel and underexploited Ubiquitin E3 ligases. It is now critical that we fully understand the structure and function of E3s and accelerate ligand screening with new and improved tools to make this process less lengthy and risky for biopharma.

The 3rd Annual Ligase Targeting Drug Development Summit is returning with fresh understandings and data from the forerunners of the field and those who have recently joined the space. Together we will investigate ligase structural and functional biology, screening tools for optimal ligase and ligand identification, and uncover the novel assays that are aiding validation.

This dedicated forum will provide an unrivaled meeting point for industry leaders to strategically accelerate and de-risk the process of identifying, validating, and therapeutically leveraging cell and tissue-specific Ubiquitin E3 ligases for degradation or modulation of targets of interest.

Read on go.evvnt.com

International Public Health Conference a top congress attracting Public Health Professionals, Nutritionists, Healthcare Experts around the globe. Worldwide healthcare experts from USA, Asia and Middle East will meet in Europe with latest research.

Read on publichealth.healthconferences.org

International Public Health Conference a top congress attracting Public Health Professionals, Nutritionists, Healthcare Experts around the globe. Worldwide healthcare experts from USA, Asia and Middle East will meet in Europe with latest research.

Read on publichealth.healthconferences.org